Prolactin Secretion Abnormalities in Patients with the “Syndrome of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity and Schwannomas” (Carney Complex)

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 4, 2000, Pages 374-380

  Raff, S B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN; PROTIRELIN; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARNEY COMPLEX; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPERPROLACTINEMIA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROLACTIN BLOOD LEVEL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYXOMA; NEURILEMMOMA; PIGMENTATION DISORDERS; PITUITARY GLAND; PROLACTIN; SYNDROME;

EID: 0034087332     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.4.374     Document Type: Article

References (32)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VLW. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985; 64: 270-283.
2. Carney JA, Young WF. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992; 2: 6-21.
3. Stratakis CA, Carney JA, Lin J-P, Karl M, Papanicolaou DA, Kastner DL, Pras E, Chrousos GP. Carney complex: a familial multiple neoplasia and lentiginosis syndrome analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996; 97: 699-705.
4. Carney JA, Headington JT, Su WPD. Cutaneous myxomas: A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol 1986; 122: 790-798.
5. Carney JA, Hruska LS, Beauchamp GD, Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin Proc 1986; 61: 165-172.
6. Premkumar A, Stratakis CA, Shawker TH, Papanicolaou DA, Chrousos GP. Testicular ultrasound in Carney complex. J Clin Ultrasound 1997; 25: 211-214.
7. Carney JA, Toorkey BC. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast: a heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol 1991; 15: 713-721.
8. Carney JA. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 1990; 14: 206-222.
9. Carney JA, Stratakis CA. Ductal adenoma of the breast and Carney complex. Am J Surg Pathol 1996; 20: 1154-1155.
10. Chrousos GP, Stratakis CA. Carney complex and the familial lentiginosis syndromes: link to inherited neoplasias and developmental disorders and genetic loci. J Intern Med 1998; 243: 573-579.
11. Stratakis CA, Kirschner LS, Taymans SE, Tomlinson IPM, Marsh D, Torpy DJ, Giatzakis C, Eccles DM, Theaker J, Houlston RS, Blouin J-L, Antonarakis SE, Basson CT, Eng C, Carney JA. Carney complex, Peutz-Jeghers syndrome, Cowden disease and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations but not genetic loci. J Clin Endocrinol Metab 1998; 83: 2977-2986.
12. Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, Korf B, Irvine AD, Hughes A, Carney JA, Stratakis CA, Basson CT. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 1998; 98: 2560-2566.
13. Stratakis CA, Jenkins RB, Pras E, Mitsiadis CS, Raff SB, Stalboerger PG, Tsigos C, Carney JA, Kastner DL, Chrousos GP. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J Clin Endocrinol Metab 1996; 81: 3607-3614.
14. DeMarco L, Stratakis CA, Boson WL, Yakbovitz O, Carson E, Adrade LM, Amaral VF, Rocha JL, Chrousos GP, Nordenskjold M, Friedman E. Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gsα gene. Hum Genet 1996; 98: 185-188.
15. Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 1998; 129: 484-494.
16. Irvine AD, Armstrong DK, Bingham EA, Hadden DR, Nevin NC, Hughes AE. Evidence for a second genetic locus in Carney complex. Br J Dermatol 1998; 139: 572-576.
17. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Ffiedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-1695.
18. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H. Growth hormoneprolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gsα protein. J Clin Endocrinol Metab 1994; 79: 1128-1134.
19. Garcia MB, Koppeschaar HIP, Lips CJ, Thijsen JH, Krenning EP. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide. J Endocrinol Invest 1994; 17: 59-65.
20. Cuttler L, Jackson JA, Uz-Zafar S, Levitsky LL, Mellinger RC, Frohman LA. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 1989; 68: 1148-1154.
21. Inada K, Oda K, Utsonomiya K, Itoh J, Osamura RY. Immunohistochemical analysis of GH-producing adenomas with special emphasis on pluri-hormonality of individual tumor cells by double staining. Tokei J Exp Clin Med 1992; 17: 213-222.
22. Asa SL, Kovacs K, Horvath E, Winger W, Smith HS. Hormonal secretion in vitro by pluri-hormonal pituitary adenomas of the acidophil cell line. J Clin Endocrinol Metab 1992; 75: 68-75.
23. Chernansky AC, Chervin A, Vitale K, Basso A, Burdman JA. Human pituitary tumors: studies on gene expression. Neurol Res 1993; 15: 2-6.
24. Yoshida T, Shimatsu A, Sakane N, Hizuda N, Horikawa R, Tanaka T. Growth hormone secretary dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like factor-1 (IGF-I) and IGF-binding protein-3 levels. J Clin Endocrinol Metab 1996; 81: 310-313.
25. Nyquist P, Laws ER Jr, Elliott E. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly. Neurosurgery 1994; 35: 179-183.
26. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T. Thyroid gland abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity” (Carney complex). J Clin Endocrinol Metab 1997; 82: 2037-2043.
27. Stratakis CA, Mastorakos G, Magiakou MA, Papavassiliou E, Panitsa-Faflia Ch, Georgiadis E, Batrinos M. 24-Hour secretion of growth hormone (GH), insulin-like growth factors-I and -II (IGF-I and -II), prolactin (PRL) and thyrotropin (TSH) in young adults of tall and normal stature. Endocr Res 1996; 22: 261-276.
28. Katz E, Adashi EY. Hyperprolactinemic disorders. Clin Obstet Gynecol 1990; 33: 622-639.
29. Bohler HCL, Jones EE, Brines NE. Marginally elevated prolactin levels require magnetic resonance imaging and evaluation for acromegaly. Fertil Steril 1994; 61: 1168-1170.
30. Melmed S. Acromegaly. N Engl J Med 1990; 322: 966-977.
31. Kovacs K, Horvath E, Thomer MO, Rogol AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virch Arch Pathol Anat 1984; 403: 77-86.
32. Landis CA, Masters SB, Spada A, Pace AM, Bourne IB, Vallar L. GTPase inhibiting mutations activate the chain of Gs and stimulate adenylate cyclase in human pituitary tumors. Nature 1989; 340: 692-696.